You are on page 1of 3

Kimberly S. Johnson 1 Conrad Court // Gales Ferry, CT 06335 // (860) 464-9331 H // (860) 235-6412 C // kj11f6c3e@westpost.

net Objective: To obtain a nursing position within a healthcare facility that will provide oppo rtunities to utilize my diverse clinical experience, education, and skills, with a preference for clinical research. Education: QUINNIPIAC UNIVERSITY - Hamden, CT; May 2010; GPA: 3.70 / 4.00 Bachelor of Science in Nursing, Accelerated Program Sigma Theta Tau International Nursing Honor Society, Graduated Magna Cum Laude UNIVERSITY OF MASSACHUSETTS - Lowell, MA; October 2006; GPA: 3.97 / 4.00 Bachelor of Science in Information Technology, Concentration in Business Alpha Sigma Lambda National Honor Society, Graduated Summa Cum Laude CENTRAL MICHIGAN UNIVERSITY - Mt. Pleasant, MI; May 1993; GPA: 3.93 / 4.00 Master of Science in Biology ALMA COLLEGE - Alma, MI; April 1990; GPA: 3.30 / 4.00 Bachelor of Science in Biology, Minors in Chemistry and French Beta Beta Beta Biological Honor Society, Dean's List, Licenses and Certificates: Cambridge Healthtech Institute; CRA / CRC Beginner Course; ACPE CEUs; April 2011 Cancer Chemo. and Bio. Course; Oncology Nursing Society; ONS Provider; Cert. #4 26785; Dec. 2010 - 2012 Registered Nurse; State of Connecticut; #095471; August 2010 - 2011 Boston University; Corporate Education Center; Certificate in Project Management ; October 2008 Clinical Experience: Institute of Living (Mental Health), Hartford Hospital, Hartford, CT Senior Prec eptorship (Spring 2010) Masonic Home Health and Hospice, Wallingford, CT Community Health (Spring 2010) Connecticut Children's Medical Center, Hartford, CT Pediatrics (Fall 2009) Hospital of St. Raphael, New Haven, CT Mental Health (Fall 2009) Hospital of St. Raphael, New Haven, CT Medical / Surgical III (Fall 2009) Yale-New Haven Hospital, New Haven, CT Maternity (Summer 2009) Hospital of St. Raphael, New Haven, CT Medical / Surgical I & II (Summer 2009) * Developed comprehensive skills in performing full head-to-toe physical assessm ents. * Administered medications via IV push, subcutaneous and IM injections, topical, and oral routes. * Gained basic familiarity with EKG interpretation, tracheostomy care, bladder s cans, blood glucose testing, and straight catherizations. * Developed skills communicating with psychiatric patients. * Co-facilitated group therapy sessions teaching basic nutrition and good eating habits at Fellowship Place. * Familiar with Pyxis patient software, basic charting, and documenting patient status. Professional Experience: Yale University via John Galt Staffing - New Haven, CT Clinical Research Nurse, 11/2010 - 1/2011 Key Accomplishments: * Performed toxicology patient assessments. * Performed EKGs.

* Scheduled patient labs and scans. * Responsible for up to seven research protocols at a time. Masonicare - Wallingford, CT Registered Nurse, 5/2010 - 8/2010 Key Accomplishments: * Performed daily patient assessments. * Administered medication via oral, ocular, rectal, subcutaneous, and intravenou s routes. * Completed admission and discharge procedures. * Educated patients and families about their medical conditions and correspondin g treatments. Pfizer, Inc. - Groton, CT Information Scientist (TA SIS Group), 2005 - 2007 Scientist (Biomarker Group), 2002 - 2004 Associate Scientist (Biomarker Group), 1997 - 2002 Assistant Scientist (Immunology Group), 1994 - 1997 Key Accomplishments: * Respected colleague with a proven ability to multitask, deliver against timeli nes, and align across departments. * Contributed to teams in Immunology, Cancer, Inflammation, Drug Safety, Pulmona ry, Central Nervous System, Cardiovascular and Metabolic Disease, Development, a nd Translational Biomarkers. * Collaborated with colleagues to identify biomarker needs and ensure proper col lection of samples from clinical trials. * Reviewed, organized, and analyzed data to ensure accuracy. * Designed and performed appropriate experiments and presented results to projec t teams via oral or poster presentations. * Accomplished information and bench scientist with extensive background in data generation, data analysis, and biomedical searching. * Provided clinical trial information found by searching relevant literature to assist in effectively powering Lyrica safety studies requested by the FDA. * Increased speed of sample throughput by 75% and reduced the cost by 86% per ge ne analyzed by implementing new biomarker sample analysis technology. * Effectively trained clinical site personnel to perform critical lab procedures supporting multiple clinical trials. * Interfaced effectively with colleagues as a reliable team player to complete p roject goals. * Provided customer-centric approach to projects as demonstrated by positive cus tomer feedback. * Received formal colleague appreciation cards for innovation, being a team play er, delivering quality products, creating an inclusive environment, and providin g quality customer service. Dow Chemical Company - Midland, MI Toxicology Technologist, 1992 - 1994 Student Technologist, 1991 - 1992 Key Accomplishments: * Performed entry-level lab duties according to established SOPs and maintained appropriate records. * Maintained sample archive and performed necessary experiments. * Participated in generation, organization, and submission of data for patent ap plication that was subsequently granted. * Received Dow Chemical Special Recognition Award. Patents: Composite Antibodies of Human Subgroup IV Light Chain Capable of Binding to TAG72. (U.S. Patent No. 5,976,531 & U.S. Patent No. 5,976,845). Humanized Anti-Tag-72 Monoclonal Antibodies Using Human Subgroup 4 Kappa Light C

hains. (U.S. Patent No. 6,495,137). Composite Antibodies of Humanized Human Subgroup IV Light Chain Capable of Bindi ng to TAG-72. (U.S. Patent No. 7,179,899). Assays for Measurement of Protein Fragments in Biological Media. (U.S. Patent N o. 6,030,792). Assays for Measurement of Type II Collagen Fragments in Urine. (U.S. Patent No. 6,642,007). Publication: Changelian, et al. Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor. Science. 302; 875-878.

You might also like